Zanganeh Mahkam Insider Trading Activity

Also formerly known as Zanganeh Maky
Average Profitability
101.68%
Insider Buys Quantity
23
Insider Buys Sum
$33.02M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Zanganeh Mahkam

According to the SEC Form 4 filings, Zanganeh Mahkam, being in a position of

  1. Co-Chief Executive Officer at Summit Therapeutics Inc.,
    оver the last 12 months, has bought 3910000 shares for $51.45M, and sold 0 shares,
    over all time since 2021-05-12, has bought 29337441 share for $86.1M, and sold 0 shares.

Biography of Zanganeh Mahkam

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $51,447,2002100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-06-12PurchaseSummit Therapeutics Inc.
SMMT
Co-Chief Executive Officer
3.81M
0.4929%
$13.12$49.99M+7.78%
2026-06-04PurchaseSummit Therapeutics Inc.
SMMT
Co-Chief Executive Officer
100,000
0.0125%
$14.60$1.46M+0.2%
2025-10-21PurchaseSummit Therapeutics Inc.
SMMT
Co-Chief Executive Officer
26,680
0.0036%
$18.74$499,983-11.63%
2025-09-11PurchaseSummit Therapeutics Inc.
SMMT
Co-Chief Executive Officer
5,000
0.0007%
$18.07$90,350-8.6%
2025-09-10PurchaseSummit Therapeutics Inc.
SMMT
Co-Chief Executive Officer
333,394
0.0451%
$17.68$5.89M-3.46%
2024-03-27PurchaseSummit Therapeutics Inc.
SMMT
Chief Executive Officer
80,321
0.0113%
$3.72$298,594+378.13%
2024-03-26PurchaseSummit Therapeutics Inc.
SMMT
Chief Executive Officer
30,000
0.0043%
$3.75$112,500+378.07%
2023-12-12PurchaseSummit Therapeutics Inc.
SMMT
Chief Executive Officer
5,000
0.0007%
$2.07$10,350+257.05%
2023-03-08PurchaseSummit Therapeutics Inc.
SMMT
Co-CEO & President
23.53M
4.2977%
$1.05$24.7M+26.97%
2022-08-16PurchaseSummit Therapeutics Inc.
SMMT
Co-CEO & President
1.03M
0.6664%
$0.97$999,997+70.3%
2021-05-12PurchaseSummit Therapeutics Inc.
SMMT
Chief Operating Officer
389,077
0.4112%
$5.24$2.04M-6.4%
2020-06-23PurchasePulse Biosciences, Inc.
PLSE
director
1,193
0.0055%
$10.70$12,767+63.04%
2020-06-17PurchasePulse Biosciences, Inc.
PLSE
director
7,950
0.0268%
$7.01$55,730+79.81%
2017-12-13PurchasePulse Biosciences, Inc.
PLSE
director
1,100
0.0066%
$23.98$26,378-36.94%
2017-12-12PurchasePulse Biosciences, Inc.
PLSE
director
1,000
0.006%
$23.98$23,979-36.78%
2017-12-11PurchasePulse Biosciences, Inc.
PLSE
director
3,000
0.0172%
$22.76$68,289-36.61%
2017-09-18PurchasePulse Biosciences, Inc.
PLSE
director
7,775
0.0559%
$15.02$116,791+22.35%
2017-09-14PurchasePulse Biosciences, Inc.
PLSE
director
22,000
0.1305%
$12.77$280,879+18.67%
2017-08-03PurchasePulse Biosciences, Inc.
PLSE
director
20,500
0.1407%
$23.48$481,332-21.36%
2017-08-02PurchasePulse Biosciences, Inc.
PLSE
director
8,290
0.0572%
$25.15$208,469-25.94%
Total: 28
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.